Immune Suppression and Colorectal Cancer

C. Evans; A. G. Dalgleish; D. Kumar


Aliment Pharmacol Ther. 2006;24(8):1163-1177. 

In This Article

Defective DC Function

As key APC, DC play a central role in the induction of antitumour immune responses. They take up, process and present tumour-specific antigens and they are responsible for the activation of tumour-specific T cells.[111] DC infiltration is associated with an immune response against the tumour[112] and correlates with improved prognosis.[113] DC form clusters with T cells at the invasive margin of colorectal cancer stroma to promote T-cell activation for the generation of tumour-specific immunity[114]and infiltration has been linked with increased disease-free survival.[115]

However, patients with colorectal cancer have reduced peripheral DC numbers with reduced T-cell stimulation capability, with low levels of DC-associated antigens and impairment of DC activation within the cancer.[116,117] Tumour cells can inhibit DC differentiation[118] with increased precursor immature myeloid cells seen which are immunosuppressive, inhibiting T-cell proliferation and tumour-specific T-cell response.[119]


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: